Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial

The National Cancer Institute–Molecular Analysis for Therapy Choice (NCI-MATCH) trial is a national signal-finding precision medicine study that relies on genomic assays to screen and enroll patients with relapsed or refractory cancer after standard treatments. We report the analytical validation pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Mol Diagn
Main Authors: Lih, Chih-Jian, Harrington, Robin D., Sims, David J., Harper, Kneshay N., Bouk, Courtney H., Datta, Vivekananda, Yau, Jonathan, Singh, Rajesh R., Routbort, Mark J., Luthra, Rajyalakshmi, Patel, Keyur P., Mantha, Geeta S., Krishnamurthy, Savitri, Ronski, Karyn, Walther, Zenta, Finberg, Karin E., Canosa, Sandra, Robinson, Hayley, Raymond, Amelia, Le, Long P., McShane, Lisa M., Polley, Eric C., Conley, Barbara A., Doroshow, James H., Iafrate, A. John, Sklar, Jeffrey L., Hamilton, Stanley R., Williams, P. Mickey
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2017
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5397672/
https://ncbi.nlm.nih.gov/pubmed/28188106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2016.10.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados